The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Vericiguat (Verquvo) is indicated to reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a worsening HF event, in adults with symptomatic chronic HF and ejection fraction less than 45%, in combination with other HF therapies.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
